Skip to search boxSkip to navigationSkip to main content

Defining the Eye-of-the-Tiger Sign

  • Kapil D. Sethi(corresponding author)
    ,
  • Shyamal H. Mehta
    ,
  • John C. Morgan
*Corresponding author for this work
Scholary Output:
Contribution to journal
Letter
Research
 Peer-review

Publication Information

Output type

Scholary Output:
Contribution to journal
Letter
Research
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Page 606 (1 page)

Journal (Volume, Issue Number)

JAMA Neurology (Volume 72, Issue 5)

Publication milestones

  • Published - 05/2015

Publication status

Published - 05/2015

ISSN

2168-6149

Publication IDs

  • Scopus: 84937217763
  • PubMed: 25961178

Access to documents

Publication metrics

Metrics

SciVal
FWCI
1.08
SciVal
Author count
3
SciVal
citations
3
SciVal
Paper percentile
46
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
1
Scopus
citations
6, opens in new tab

PlumX, opens in new tab

Captures
7
Citation count
6

Funding Details

Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Author Affiliations: Movement Disorders Program, Department of Neurology, Georgia Regents University, Augusta (Sethi, Morgan); Movement Disorders Division, Department of Neurology, Mayo Clinic, Scottsdale, Arizona (Mehta). Corresponding Author: Kapil D. Sethi, MD, FRCP(UK), Movement Disorders Program, Department of Neurology, Georgia Regents University, 1429 Harper St, Augusta, GA 30912 ([email protected]). Conflict of Interest Disclosures: Dr Sethi is a part-time employee of Merz Pharmaceuticals and has served as a consultant for Teva Pharmaceutical Industries, Impax Laboratories, Lundbeck, Synosia Therapeutics, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. Dr Sethi has received grant support from Kyowa, Acadia Pharmaceuticals, and AbbVie. Dr Morgan has served as a consultant for Teva Pharmaceutical Industries, Lundbeck, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. No other disclosures were reported. Funding/Support: Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Role of the Funder/Sponsor: The funders had no role in the preparation, review, or approval of the manuscript, and the decision to submit the manuscript for publication. 1. Pandey S, Byler DL, Hallett M. Hemidystonia with one eye-of-the-tiger sign. JAMA Neurol. 2014;71(12):1574-1575. 2. Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol. 1988;24(5): 692-694.
FundersFunding numbers
Kyowa
-
NIH
-
FNIH
-
NPF
-
AbbVie
-
ACADIA
-